Novacyt schedules annual meeting for June 30
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Novacyt (ALNOV)
Assess today's live Novacyt (ALNOV) share price, performance and insights using our live Paris: ALNOV stock exchange data.
Analyse the historical data and Novacyt share price performance charts on this page. Our technical summary section provides analysis on Novacyt share price buy/sell indicators using real-time data (or discuss the Novacyt (ALNOV) stock price today with other investors in the Novacyt EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA ALNOV share price (ISIN: FR0010397232) to enhance your trading decisions with our free investment tools and resources.
What Is the Novacyt Share Price Today?
The Novacyt share price today is 0.5800.
What Is the Stock Symbol for Novacyt
The stock symbol (or 'ticker') for Novacyt is "ALNOV."
What Stock Exchange Does Novacyt Trade On?
Novacyt is listed and trades on the Paris stock exchange.
Is Novacyt a Good Stock to Buy?
Determining whether Novacyt—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Novacyt share price performance charts on this page. Our technical summary section provides analysis on Novacyt share price buy/sell indicators using real-time data (or discuss the Novacyt (ALNOV) stock price today with other investors in the Novacyt EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA ALNOV share price (ISIN: FR0010397232) to enhance your trading decisions with our free investment tools and resources.
What Is the Novacyt Share Price Today?
The Novacyt share price today is 0.5800.
What Is the Stock Symbol for Novacyt
The stock symbol (or 'ticker') for Novacyt is "ALNOV."
What Stock Exchange Does Novacyt Trade On?
Novacyt is listed and trades on the Paris stock exchange.
Is Novacyt a Good Stock to Buy?
Determining whether Novacyt—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
0.5800
+0.0050(+0.87%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5490
0.6180
52 wk Range
0.2900
1.0400
Earnings results expected in 12 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.54900.6180
52 wk Range
0.29001.0400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALNOV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Novacyt CSO Joanne Mason steps down from board
- Investing.com
- Novacyt schedules annual meeting for June 30
- Investing.com
- Novacyt CSO Joanne Mason steps down from board
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Novacyt Earnings Call Summary for H2/2025
- Novacyt reported £20M revenue for 2025, up 4% organically, with net loss narrowing to £22.9M from £42M prior year.
- Stock plunged 9.36% to £0.3205 despite beating expectations, driven by cash flow concerns and £15.9M exceptional costs.
- Cash position weakened to £11M, down £11M year-over-year, raising investor concerns about liquidity and financial stability.
- Company forecasts £26.4M revenue for 2026, focusing on R&D investments and new product launches to drive profitability growth.
- Maintained 63% gross margin at £12.6M; EBITDA loss improved 14% to £7.8M amid continued operational efficiency efforts.
Last Updated: 04/05/2026, 09:04
Read Full TranscriptEarnings
Latest Release
30/04/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare ALNOV to Peers and Sector
Metrics to compare | ALNOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALNOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −1.7x | −0.5x | |
PEG Ratio | −0.03 | −0.10 | 0.00 | |
Price/Book | 1.5x | 1.2x | 2.6x | |
Price / LTM Sales | 1.8x | 3.0x | 3.1x | |
Upside (Analyst Target) | - | 33.8% | 53.0% | |
Fair Value Upside | Unlock | 18.7% | 6.3% | Unlock |
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.
Ownership
Ownership Overview
People Also Watch
FAQ
What Is the Novacyt (Paris: ALNOV) Share Price Today?
The Novacyt stock price today is 0.5800 EUR.
What Stock Exchange Does Novacyt (ALNOV) Trade On?
Novacyt is listed and trades on the Paris Stock Exchange.
What Is the Ticker (Stock Symbol) for Novacyt?
The stock symbol (also called a 'ticker') for Novacyt is "ALNOV."
What Is the Current Novacyt Market Capitalisation?
As of today, Novacyt (Paris: ALNOV) market cap is 42.3200M EUR.
What Is Novacyt's (ALNOV) Earnings Per Share (TTM)?
The Novacyt EPS is currently -0.3280 (Trailing Twelve Months).
When Is the Next Novacyt Earnings Date?
Novacyt's next earnings report will be released on 03/06/2026.
Is ALNOV a Buy or Sell From a Technical Analyst Perspective?
Based on today's Novacyt moving averages and other technical indicators, the daily buy/sell signal for ALNOV stock is Neutral.
How Many Times Has Novacyt Stock Split?
Novacyt has split 0 times. (See the ALNOV stock split history page for full effective split date and price information.)
How Many Employees Does Novacyt Have?
Novacyt has 234 employees, based on their latest Companies House report.
What is the current trading status of Novacyt (Paris: ALNOV)?
As of 22/05/2026, Novacyt (ALNOV) is trading at a share price of 0.5800 EUR, with a previous close of 0.5750 EUR. The stock has fluctuated within a day range of 0.5490 EUR to 0.6180 EUR, while its 52-week range spans from 0.2900 EUR to 1.0400 EUR.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.